Serum Albumin Nanoparticles: Problems and Prospects

The present paper aims to summarize the results regarding serum albumin-based nanoparticles (NPs) for drug delivery purposes. In particular, it focuses on the relationship between their preparation techniques and synthesis parameters, as well as their successful clinical application. In spite of the...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Viktória Hornok
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	serum albumin nanoparticles drug delivery protein carriers Organic chemistry QD241-441
Acceso en línea:	https://doaj.org/article/65da11d85b9945cd8b0e01ce78321806
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:65da11d85b9945cd8b0e01ce78321806
record_format	dspace
spelling	oai:doaj.org-article:65da11d85b9945cd8b0e01ce783218062021-11-11T18:46:33ZSerum Albumin Nanoparticles: Problems and Prospects10.3390/polym132137592073-4360https://doaj.org/article/65da11d85b9945cd8b0e01ce783218062021-10-01T00:00:00Zhttps://www.mdpi.com/2073-4360/13/21/3759https://doaj.org/toc/2073-4360The present paper aims to summarize the results regarding serum albumin-based nanoparticles (NPs) for drug delivery purposes. In particular, it focuses on the relationship between their preparation techniques and synthesis parameters, as well as their successful clinical application. In spite of the huge amount of consumed material and immaterial sources and promising possibilities, products made from different types of albumin NPs, with the exception of a few, still have not been invented. In the present paper, promising applications of serum albumin nanoparticles (SANPs) for different biomedical purposes, such as carriers, delivery systems and contrast agents, are also discussed. The most frequent utilization of the NPs for certain diseases, i.e., cancer therapy, and future prospects are also detailed in this study.Viktória HornokMDPI AGarticleserum albuminnanoparticlesdrug deliveryprotein carriersOrganic chemistryQD241-441ENPolymers, Vol 13, Iss 3759, p 3759 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	serum albumin nanoparticles drug delivery protein carriers Organic chemistry QD241-441
spellingShingle	serum albumin nanoparticles drug delivery protein carriers Organic chemistry QD241-441 Viktória Hornok Serum Albumin Nanoparticles: Problems and Prospects
description	The present paper aims to summarize the results regarding serum albumin-based nanoparticles (NPs) for drug delivery purposes. In particular, it focuses on the relationship between their preparation techniques and synthesis parameters, as well as their successful clinical application. In spite of the huge amount of consumed material and immaterial sources and promising possibilities, products made from different types of albumin NPs, with the exception of a few, still have not been invented. In the present paper, promising applications of serum albumin nanoparticles (SANPs) for different biomedical purposes, such as carriers, delivery systems and contrast agents, are also discussed. The most frequent utilization of the NPs for certain diseases, i.e., cancer therapy, and future prospects are also detailed in this study.
format	article
author	Viktória Hornok
author_facet	Viktória Hornok
author_sort	Viktória Hornok
title	Serum Albumin Nanoparticles: Problems and Prospects
title_short	Serum Albumin Nanoparticles: Problems and Prospects
title_full	Serum Albumin Nanoparticles: Problems and Prospects
title_fullStr	Serum Albumin Nanoparticles: Problems and Prospects
title_full_unstemmed	Serum Albumin Nanoparticles: Problems and Prospects
title_sort	serum albumin nanoparticles: problems and prospects
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/65da11d85b9945cd8b0e01ce78321806
work_keys_str_mv	AT viktoriahornok serumalbuminnanoparticlesproblemsandprospects
_version_	1718431706106560512

Serum Albumin Nanoparticles: Problems and Prospects

Ejemplares similares